Art
J-GLOBAL ID:200902100377530744   Reference number:01A1010563

Effects of Recombinant Human Erythropoietin Therapy on Blood Coagulation and Fibrinolysis System.

血液凝固と線溶系に与える組換ヒトエリスロポイエチン療法の効果
Author (9):
Material:
Volume:Issue:Page: 273-277  Publication year: Oct. 2001 
JST Material Number: Y0501B  ISSN: 1341-1098  Document type: Article
Article type: 原著論文  Country of issue: Japan (JPN)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=01A1010563&from=J-GLOBAL&jstjournalNo=Y0501B") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for cardiovascular system diseases  ,  Cytokines 
Reference (17):
  • WATANABE, Y. Autologous blood transfusion with recombinant human erythropoietin in heart operations. Ann Thorac Surg. 1991, 51, 767-772
  • KONISHI, T. Effectiveness of erythropoietin for cardiovascular surgery to prevent homologous blood transfusions. Jpn J Thorac Cardiovasc Surg. 1993, 41, 187-191
  • JAAR, B. Effects of long-term treatment with recombinant human erythropoietin on physiologic inhibitors of coagulation. Am J Nephrol. 1997, 17, 399-405
  • KRZESLOWSKA, J. Expression of fibrinogen receptors and GPIIb molecules on uraemic platelets : effects of recombinant human erythropoietin therapy. Nephrol Dialysis Transplant. 1995, 10, 653-656
  • HIROMATSU, T. Fatal pulmonary embolism occurring after hip joint operation with autologous blood transfusion and concomitant EPO therapy. J Jpn Autologous Blood Transfusion. 1991, 4, 97-99
more...

Return to Previous Page